Evidence map›Paper›PMID 22503637›Full record

ReviewTrends in microbiology2012

Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice.

Paul W Denton, J Victor Garcia

Abstract readReview
In one paragraph

Review in Trends in microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Humanized mice for HIV and AIDS research.Current opinion in virology · 2016
    Review
  16. Article
  17. Cell-to-Cell Spread of HIV and Viral Pathogenesis.Advances in virus research · 2016
    Review
  18. Application of Humanized Mice in Immunological Research.Methods in molecular biology (Clifton, N.J.) · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Paul W DentonDivision of Infectious Diseases, UNC Center for AIDS Research, University of North Carolina, School of Medicine, Genetic Medicine Building 2044, Chapel Hill, NC 27599-7042, USA.
J Victor Garcia

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Vaginal/Rectal HIV Transmission ModelR01AI073146 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GARCIA-MARTINEZ, J. VICTOR · 2007 to 2016
$4.8M
Implementation of a vaginal/rectal HIV transmission to model to evaluate microbicR33AI071940 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GARCIA-MARTINEZ, J. VICTOR · 2008 to 2010
$1.6M
Implementation of a vaginal/rectal HIV transmission to model to evaluate microbicR21AI071940 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GARCIA-MARTINEZ, J. VICTOR · 2006 to 2007
$406k
NIAID NIH HHS AI071940NIAID NIH HHS AI073146NIAID NIH HHS P30 AI050410NIAID NIH HHS R01 AI073146NIAID NIH HHS R21 AI071940NIAID NIH HHS R33 AI071940
6 · The paper itself

Abstract

Clinical trials testing microbicides and related biomedical interventions to block HIV transmissions have produced contradictory results and to date it is unclear why. Further elucidation of the molecular basis of mucosal HIV transmission and extensive pharmacokinetic and pharmacodynamic analyses are essential to implementing effective prevention strategies. Animal models are of critical importance to this effort and bone marrow-liver-thymus (BLT) humanized mice have recently emerged as a powerful small animal research platform for in vivo efficacy evaluation of mucosal and parenteral HIV-1 prevention interventions. The availability of this validated system for the pre-clinical evaluation of HIV-1 prevention approaches will accelerate the implementation of the best candidate interventions into clinical trials.

Indexed as

Immunity, MucosalAnimalsDisease Models, AnimalDisinfectantsHIV-1HIV InfectionsHumansMiceMice, SCIDMice, TransgenicMucous MembraneTreatment OutcomeDisinfectants

Identifiers

PMID22503637
PMCPMC3680353

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.